Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.

Women diagnosed with pelvic organ prolapse in emergency departments in the United States lack timely outpatient follow-up, ...

Prohibited from serving with the U.S. Army as a medical officer, Barbara Stimson was commissioned by the British—and helped ...